May 24, 2016
The Lalit Hotel
Mumbai, India
via Virtue Insight
7th Annual Clinical Trials Summit 2016
"A critical guide for successfully conducting clinical trials"
Conference Introduction: The clinical trial market in India looks very lucrative. India has several unique features for being a hot spot for the clinical trial market. As a signatory to the World Trade Organization agreements, India is looked upon as a favorable destination for conducting global clinical trials. There are many opportunities and challenges for conducting global clinical trials in India. In a majority of cases, these drugs are aimed at providing answers to unmet medical needs.
Clinical research is important not only for developing medicines for emerging health concerns (such as antibiotic resistant pathogens, H1N1, Dengue, , etc.) also for finding safe and better medicines for entrenched diseases such as HIV, Malaria, tuberculosis (especially drug resistant TB) Diabetes, Hypertension, Cancer, heart failure etc. India, with its large patient population, and limited resource has significant unfilled health needs. We should make the newest and best treatment option to be avail to the population and to the patient’s globally. For this, India must proactively take part in conducting clinical research (“Research for India”) and assume leadership role globally (“made for the world”). As we are operating in a new regulatory and operational environment, we have a great task ahead of us – strengthening the sites, Investigators, Ethics Committees and empowering the patient who is the center of the clinical research enterprise.
For more information, click here.
